Role of Liposomes Composite as Drug Transport Mechanism
P. Senthil Kumar, P.R. Yaashikaa
Liposomes are spherical shaped vesicles comprising of at least one phospholipid bilayer that serve as a novel drug delivery framework. They are microscopic structures in which a fluid system is totally encased by a film made out of lipid bilayers. It varies in size, conformation, charge and drug transporter stacked with assortment of particles, for example, small molecules of drug, plasmids, nucleotides or proteins and so on. Ongoing advances in nanotherapeutics have brought about engineered liposomes rising in nanomedicine, giving better restorative control of diseased states. This has made ready for the improvement of second-stage liposomes for increased efficiency and could at last lead to a change in perspective from the regular drug delivery methods.
Keywords
Drug Delivery, Liposomes, Methods and Mechanism, Target, Therapeutics
Published online 11/20/2020, 14 pages
Citation: P. Senthil Kumar, P.R. Yaashikaa, Role of Liposomes Composite as Drug Transport Mechanism, Materials Research Foundations, Vol. 87, pp 230-243, 2021
DOI: https://doi.org/10.21741/9781644901076-9
Part of the book on Nanohybrids
References
[1] T.M. Allen, C. Hansen, J. Rutledge, Liposomes with prolonged circulation times—Factors affecting uptake by reticuloendothelial and other tissues, Biochimica et Biophysica Acta, 981 (1989) 27–35. https://doi.org/10.1016/0005-2736(89)90078-3
[2] M. Alavi, N. Karimi, M. Safaei, Application of various types of liposomes in drug delivery systems, Advanced Pharmaceutical Bulletin, 7 (2017) 3-9. https://doi.org/10.15171/apb.2017.002
[3] T.M. Allen, P.R. Cullis, Liposomal drug delivery systems: From concept to clinical applications, Advanced Drug Delivery Reviews, 65 (2013) 36-48. https://doi.org/10.1016/j.addr.2012.09.037
[4] C. Chen, D. Han, C. Cai, X. Tang, An overview of liposome lyophilization and its future potential, Journal of Controlled Release, 142 (2010) 299–311. https://doi.org/10.1016/j.jconrel.2009.10.024
[5] N. Duzgunes, G. Gregoriadis, Introduction: The origins of liposomes: Alec Bangham at Babraham, Liposomes, Pt E, 391 (2005) 1–3. https://doi.org/10.1016/S0076-6879(05)91029-X
[6] J. Kunisawa, S. Nakagawa, T. Mayumi, Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development, Advanced drug delivery reviews, 52 (2001) 177-186. https://doi.org/10.1016/S0169-409X(01)00214-9
[7] S. Hua, S.Y. Wu, The use of lipid-based nanocarriers for targeted pain therapies, Frontiers in Pharmacology, 4 (2013) 143. https://doi.org/10.3389/fphar.2013.00143
[8] H. Daraee, A. Etemadi, M. Kouhi, S. Alimirzalu, A. Akbarzadeh, Application of liposomes in medicine and drug delivery, Artificial Cells, Nanomedicine, and Biotechnology, 44 (2016) 381-391. https://doi.org/10.3109/21691401.2014.953633
[9] L. Sercombe, T. Veerati, F. Moheimani, S.Y. Wu, A.K. Sood, S. Hua, Advances and challenges of liposome assisted drug delivery, Frontiers in Pharmacology, 6 (2015) 286. https://doi.org/10.3389/fphar.2015.00286
[10] G. Bozzuto, A. Molinari, Liposomes as nanomedical devices, International Journal of Nanomedicine, 10 (2015) 975-999. https://doi.org/10.2147/IJN.S68861
[11] Y. Lee, D.H. Thompson, Stimuli-responsive liposomes for drug delivery, Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 9 (2017) 1-40. https://doi.org/10.1002/wnan.1450
[12] L. Zhu, V.P. Torchilin, Stimulus-responsive nanopreparations for tumor targeting, Integrative Biology, 5 (2013) 96-107. https://doi.org/10.1039/c2ib20135f
[13] V. Torchilin, Multifunctional and stimuli-sensitive pharmaceutical nanocarriers, European Journal of Pharmaceutics and Biopharmaceutics, 71 (2009) 431-444. https://doi.org/10.1016/j.ejpb.2008.09.026
[14] H. Elsana, T.O.B. Olusanya, J. Carr-wilkinson, S. Darby, A. Farheem, A.A. Elkordy, Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems, Scientific Reports, 9 (2019) 15120. https://doi.org/10.1038/s41598-019-51065-4
[15] M. Hara, J. Miyake, Calcium alginate gel-entrapped liposomes, Materials Science and Engineering C, 17 (2001) 101–105. https://doi.org/10.1016/S0928-4931(01)00316-2
[16] X. Li, L. Ding, Y. Xu, Y. Wang, Q. Ping, Targeted delivery of doxorubicin using stealth liposomes modified with transferrin, International Journal of Pharmaceutics, 373 (2009) 116–123. https://doi.org/10.1016/j.ijpharm.2009.01.023
[17] P. Pradhan, J. Giri, F. Rieken, Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy, Journal of Controlled Release, 142 (2010) 108–121. https://doi.org/10.1016/j.jconrel.2009.10.002
[18] S. Jain, P. Jain, R.B. Umamaheshwari, N.K. Jain, Transfersomes—A novel vesicular carrier for enhanced transdermal delivery: Development, characterization, and performance evaluation, Drug development and industrial Pharmacy, 29 (2003) 1013–1026. https://doi.org/10.1081/DDC-120025458
[19] P.S. Zangabad, S. Mirkiani, S. Shahsavari, B. Masoudi, M. Masroor, H. Hamed, Z. Jafari, Y.D. Taghipour, H. Hashemi, M. Karimi, M.R. Hamblin, Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications, Nanotechnology Review, 7 (2018) 95-122. https://doi.org/10.1515/ntrev-2017-0154
[20] B.M. Dicheva G.A. Koning, Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors, Expert opinion on drug delivery, 11 (2014) 83–100. https://doi.org/10.1517/17425247.2014.866650
[21] A. Schnyder, J. Huwyler, Drug transport to brain with targeted liposomes, NeuroRx, 2 (2005) 99–107. https://doi.org/10.1602/neurorx.2.1.99
